Carcinoma of the vulva

Area of Science:

• Gynecologic Oncology
• Surgical Oncology

Background:

• Vulvar cancer is a rare malignancy affecting women, with squamous cell carcinoma being the most common histological type.
• Treatment strategies have evolved, necessitating analysis of historical data to inform current practices.

Purpose of the Study:

• To evaluate the treatment outcomes and survival rates for patients with vulvar carcinoma.
• To assess the impact of different treatment modalities, including surgery and radiation, on patient prognosis.

Main Methods:

• Retrospective analysis of 96 patients treated for vulvar carcinoma between 1966 and 1981.
• Review of treatment modalities: vulvectomy, hemivulvectomy, electroresection, radical surgery, and radiation therapy.
• Histopathological analysis and survival rate calculation (5-year survival).

Main Results:

• The average age at diagnosis was 69 years; keratinizing squamous cell carcinoma was prevalent (78.2%).
• Radical surgery followed by radiation yielded a 5-year survival rate of 44.4%, compared to 38.5% without radical surgery.
• Radiation therapy was frequently used in conjunction with surgical interventions.

Conclusions:

• Radical surgery, especially when combined with adjuvant radiation, appears to be associated with improved survival in vulvar cancer patients.
• Treatment decisions should consider the extent of disease and patient factors to optimize outcomes for vulvar carcinoma.